Inve India ▾
ININNOVACAP

Innova Captab Q3 FY26 results (Oct–Dec 2025) and concall

Healthcare · Concall AI · Call held 27 Jan 2026

Innova Captab delivered a stellar Q3 FY26, driven by strong performance across both CDMO and branded generics segments. The company reported significant revenue and profitability growth, supported by strategic focus and operational discipline. The new Jammu facility is ramping up smoothly, contributing substantially to revenue and is expected to turn profitable at the EBITDA level in the next fiscal year.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q3 FY26: revenue up 42.4%, net profit up 23.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue318 316 315 352 380 +19%450 +42%
EBITDA50 47 48 52 52 +4%69 +47%
Net profit35 34 30 31 30 −14%42 +24%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.